nutraceutical
SAN DIEGO, CA, March 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® will host its Europe Regional Event in Prague on March 5 and 6, 2022. […]
Toronto, Ontario–(Newsfile Corp. – October 14, 2021) – Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) (“Glow” or the “Company“) is pleased to provide an update on new appointments to support the Company’s advancing manufacturing and commercial initiatives including the appointment of Josh Bald, CPA as Glow’s dedicated CFO. As with many industries, […]
Levitee currently operates two units, Sporeo Supply and Monk-E Nutraceuticals, while aggressively targeting cash flowing wellness assets through accretive M&A Multiple letters of intent executed for acquisitions of addiction & pain clinics, pharmacies, an omnichannel superfoods and supplements brand and a late-stage applicant for a Health Canada Dealer’s License Over CDN$12 million raised to date […]
RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands
TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) today announces that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers for use in a pilot study to be conducted by Medicann in Jersey, the largest of the Channel Islands, located between England and […]
Pure Extracts Unveils Plans for Functional Mushrooms
There are more than 2,000 species of edible fungi and at least 15 have functional benefits that support overall health. Like other superfoods, functional mushrooms have antioxidant properties that support the immune system, dietary fiber to aid in healthy digestion and numerous other benefits to everything from mental clarity to skin health. At the […]
CBD Makes Its Way into Mainstream Retail
The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]
3 Beverage Mega-Trends that Investors Should Watch
Beverages play a key role in almost everyone’s life—from coffee in the morning to an alcoholic drink at dinner or with friends. While the same large companies have dominated the space for years, smaller innovators have experienced the fastest growth rates as they launch high-growth products before getting snapped up by larger competitors. The key […]
Science-driven Brand Delivers 5 Perfected Cannabis Highs
What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a […]
Adaptogens, Functional Beverages, and CBD
It’s a stressful world out there, and consumers know it. In growing numbers, people are looking for healthy foods, naturally sourced, to keep both themselves and the planet on a positive track. If those foods can also relieve stress and help people relax, all the better. Beverages are a prime example of the trend toward […]
Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support
Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid […]
The Yield Growth Corp. Keeps Growing Like a Weed…or a Mushroom
While some companies are scratching their heads about what to make of the brutal treatment cannabis stocks have felt this year, The Yield Growth Corp. (CSE: BOSS)(OTCQB: BOSQF) seems undaunted, expanding its cannabis business while rapidly emerging as a leading public company in the mushroom space. Click here to receive an investor deck and corporate […]
CBD Playing an Increasing Role in Health & Wellness
The legalization of cannabis has enabled far greater research into the potential medicinal benefits offered by the plant – especially cannabidiol (CBD), the most abundant non-psychoactive cannabinoid found in both cannabis and hemp. This increased research has led to the creation of hundreds of new and innovative alternatives to health and wellness products. Rapidly Changing […]
XPhyto Therapeutics: Where Medical Cannabis Meets Modern Science
It wasn’t long ago that recreational marijuana was legalized in Washington State and Colorado, while speculation about widespread medical marijuana was running rampant across America and then-Canadian Prime Minister candidate Justin Trudeau was making campaign promises for his country to become the second in the world with adult-use marijuana. At that time, so-called “pot […]
Yield Growth Enters European Market, Setting Itself Up for Global Success
The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3) is a company dedicated to disrupting the health and wellness industry, with its many subsidiaries offering both CBD and THC infused products. By targeting specific niches of the cannabis industry, the company has seen great success both in the US and Canada. Now they turn […]
Yield Growth Clears Final Hurdle to Market Six New Products in Oregon
The cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a blistering 23.9% compound annual growth rate. While medical and adult-use cannabis capture the headlines, cannabinoid-infused topicals, tinctures and capsules could become some of the fastest growing subsets of the market. Investors may want to take a […]
Supreme Cannabis Continues To Achieve Milestones in 2019
The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year and the upcoming legalization of edibles later this year. While many companies have focused on scaling up their production capacity at any cost, investors may want to shift focus […]
Yield Growth Achieves Revenue of $3.1 Million for Its Fiscal Year Ended November 30, 2018
VANCOUVER, British Columbia, March 22, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF) (Frankfurt: YG3) on a consolidated basis (the “Company”) has released its financial and operational results for the year ended November 30, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com. UPDATE ON CASH POSITION The Company received warrant […]
Creso Pharma Secures Canadian License to Cultivate in Nova Scotia
Creso Pharma Inc.(ASX: CPH) is a commercial-stage company that operates in multiple parts of the burgeoning cannabis industry. With an existing line of health and wellness products, the company is actively generating revenue across European markets. The company’s recently granted license to cultivate in Nova Scotia provides additional exposure to Canada’s recreational and medical markets and […]
Yield Growth lists on the U.S. OTCQB Venture Market under the Symbol “BOSQF”
VANCOUVER, British Columbia, Feb. 01, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce that the OTCQB Venture Market has approved the listing of the company’s shares on the OTCQB market under the ticker symbol “BOSQF” and that trading will begin at market open on February 1, 2019. The company […]
Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company has filed an international patent application to protect this work for […]
NanoSphere Closes $1.335M First Tranche of Private Placement
DENVER–(BUSINESS WIRE)–NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the patented NanoSphere Delivery System™, is pleased to announce a first tranche closing of its non-brokered private placement announced November 28, 2018. Pursuant to the first tranche, the company issued 4,452,254 Units at a price of $0.30 per Unit for gross proceeds […]
Creso Pharma: A Truly Global Cannabis Company
The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many of these announcements are speculative at best, requiring a mix of regulatory approvals, licensing, product development, […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Plus Products, through its wholly-owned subsidiary, Carberry, operates as a branded cannabis products manufacturer with operations in California.
Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
